Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of antihelmentic, anti-parasites, antiprotozoal, NSAID, anti-bacterial, phosphorus supplement, beta agonist, analgesic, antimetic, anti- allergic, and congestive heart failure. It also offers analytical services; and finished dosage formulations, and VET formulation. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Metrics to compare | SEQU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSEQUPeersSector | |
---|---|---|---|---|
P/E Ratio | 199.9x | 15.0x | −0.5x | |
PEG Ratio | 1.28 | 0.00 | 0.00 | |
Price/Book | 6.2x | 1.2x | 2.6x | |
Price / LTM Sales | 2.8x | 1.3x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 9.5% | 7.1% | Unlock |